Knowles Corporation account plan
Manufactures specialty electronic components
At a glance
Knowles makes specialty capacitors, RF filters and hearing-health audio components, with $593.2 million of FY2025 revenue and about 5,200 employees.
Knowles Corporation, founded in 1946 and headquartered in Itasca, Illinois, makes specialty electronic components: high-performance capacitors, RF filters, microphones and balanced armature speakers for medtech, defense, industrial and electrification/energy markets. FY2025 revenue was $593.2 million (+7.2%), Adjusted EBIT $120.1 million (20.2% margin) and non-GAAP diluted EPS $1.11. It had approximately 5,200 employees in 11 countries at December 31, 2025, with most manufacturing in Asia plus plants in the U.S. and Mexico. Knowles is listed on the NYSE under the ticker KN.
Business units
Precision Devices (PD)
55% of FY2025 revenue ($328.9 million)High-performance and specialty film capacitors (including Cornell Dubilier) and RF filters for defense, industrial, medtech and electrification/energy customers, made in North America and Asia. Revenue rose 9.6% in 2025 and 32.7% to $117.0 million in Q3 2026, with book-to-bill of 1.5.
MedTech & Specialty Audio (MSA)
45% of FY2025 revenue ($264.3 million)Balanced armature speakers and microphones for hearing health and specialty audio, sold to hearing health manufacturers led by WS Audiology and made in Cebu, Penang and Suzhou. Revenue rose 4.3% in 2025 at a 38.7% Adjusted EBIT margin and 3.6% to $67.0 million in Q3 2026.
Strategic priorities
- Industrial technology portfolio
- Knowles is pursuing its transformation into a premier industrial technology company, after selling Consumer MEMS Microphones to Syntiant in December 2024 and buying Cornell Dubilier in 2023 for $259.8 million.
- Precision Devices capacity
- PD is close to capacity constraints; new capacity across most PD lines comes online from late Q1, fully available in the second half of 2027, with capex rising to 5% to 7% of revenue in 2027.
- Defense growth
- Defense is growing faster than expected in May 2025; filters are roughly $80 million, about ninety percent defense, and management sees a possible acceleration in the next 12 to 18 months.
- Expanding the addressable market
- New products for existing markets (attenuators, inductors), existing technologies for new customers (Micro Solutions, pulse power capacitors) and more content at current customers; Micro Solutions should reach north of $5 million in 2027.
- Margin expansion
- Management targets 100 basis points of gross margin gain a year plus operating leverage, moving from just over 25% EBITDA margin in 2026 to 30% within 2 to 3 years.
- Selective M&A
- Knowles is looking for another Cornell-type acquisition over the next year or two, with three full-time people working on M&A.
Latest results
In Q3 2026 revenue was $184.0 million, up 20.3%, Adjusted EBIT $42.4 million (23.0% margin) and non-GAAP diluted EPS $0.38 versus $0.33. Nine-month revenue was $503.9 million, up 16.9%, driven by Precision Devices (+25.6%). The non-GAAP gross margin dipped to 45.3% in Q3 on inventory adjustments, factory costs, mix and ceramic capacitor production transfer costs. Q4 2026 guidance is revenue of $180 million to $190 million and EPS of $0.39 to $0.43, with full-year 2026 revenue growth of 16% at the midpoint and adjusted EBITDA growth of 24%.
Investments and deals
- Specialty film and PD capacity
- 2025 capex was $32.1 million (5.4% of revenue), mainly specialty film capacity; 2026 capex is expected at approximately 5% of revenue and 5% to 7% in 2027.
- Cornell Dubilier acquisition
- Acquired on November 1, 2023 for $259.8 million; its gross margin rose from 27%-28% at acquisition to the mid-30s.
- Consumer MEMS Microphones divestment
- Sold to Syntiant on December 27, 2024 for approximately $141.9 million in total consideration.
- Share buybacks and debt paydown
- In 2025 Knowles repaid $72.7 million of the CD Seller Note and bought back $65.0 million of shares; nine-month 2026 buybacks were $47.5 million.
Challenges and risks
- Customer concentration
- WS Audiology was 11% of 2025 revenue and distributor TTI 10%; MSA relies on a limited number of customers.
- China and trade policy
- U.S.-China tariffs and China's localization policy have hurt PD revenue, and most manufacturing sits in Asia.
- Capacity and yields
- PD is close to capacity constraints, and ramping the specialty film line brought lower-than-expected yields in the CD business in 2025.
- MSA pricing and stamping exit
- MSA margins are pressured by mature-product price erosion and higher factory costs, and the stamping supply business ends with a last-time buy at year end.
- Supply and government rules
- Some critical inputs are sole-sourced, precious-metal prices affect costs, and PD must comply with U.S. government contracting rules.
What leadership says
“We don't really see our prices go down.”
“with it being fully available in the second half of 2027”
“a sole source supplier on a number of key defense programs”
Where a supplier can help
- Factory capacity and automation
- Tied to the Precision Devices capacity build: equipment, automation and productivity suppliers can help bring new lines online by the second half of 2027 and support the margin targets.
- Yield and quality improvement
- Tied to lower-than-expected specialty film yields and production transfer costs: process control and quality tools address a stated cost drag.
- Recruiting for PD growth
- Tied to added PD headcount to support future growth: recruiting and onboarding services fit a segment growing over 30% in Q3 2026.
- Supply chain resilience
- Tied to sole-sourced inputs, tariffs and Asia exposure: alternative sourcing, trade compliance and precious-metal supply offers address named risks.
- M&A support
- Tied to the search for another Cornell-type acquisition: deal sourcing, due diligence and integration services fit a stated priority.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Knowles Corporation?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Knowles Corporation Annual Report on Form 10-K, fiscal year ended December 31, 2025
- Knowles is a specialty electronic components maker (founded 1946, Itasca, Illinois; about 5,200 employees in 11 countries) selling high-performance capacitors, RF filters, medtech microphones and balanced armature speakers into medtech, defense, industrial and electrification/energy markets.
- FY2025 revenue was $593.2 million (+7.2%); Adjusted EBIT $120.1 million (20.2% margin); non-GAAP diluted EPS $1.11 versus $0.92; adjusted free cash flow $114.4 million (19.3% of revenue).
- Precision Devices (55% of revenue, $328.9 million, +9.6%) is the growth engine: capacitors (incl. Cornell Dubilier specialty film) and RF filters for defense, medtech, industrial and energy, Adjusted EBIT margin up to 19.2%.
- MedTech & Specialty Audio (45%, $264.3 million, +4.3%) supplies hearing aid makers, with a 38.7% Adjusted EBIT margin. WS Audiology was 11% of group revenue; distributor TTI was 10%.
- Portfolio pivot to a "premier industrial technology company" (May 2025 investor day): Consumer MEMS Microphones sold to Syntiant in December 2024 for about $141.9 million; Cornell Dubilier bought in 2023 for $259.8 million.
- 2025 capex was $32.1 million (5.4% of revenue), mainly specialty film capacity; 2026 capex is guided at 4% to 5% of revenue. $72.7 million of CD Seller Note was repaid and $65.0 million of shares bought back.
- Manufacturing is mostly in Asia (Suzhou, Cebu, Penang) plus U.S./Mexico PD plants. Key risks: customer concentration, U.S. government contract rules, China's localization policy hurting PD, tariffs, sole-source suppliers, precious-metal prices.
- Leadership: Jeffrey S. Niew, President & CEO since 2013; John S. Anderson, CFO; Daniel J. Giesecke, COO; Raymond D. Cabrera, CHRO; Robert J. Perna, General Counsel.
- Knowles Corporation Quarterly Report on Form 10-Q, quarter ended September 30, 2026
- Q3 2026 revenue was $184.0 million, up 20.3%; nine-month revenue was $503.9 million, up 16.9%.
- Precision Devices Q3 revenue was $117.0 million (+32.7%) on electrification, industrial, defense and medtech demand plus higher pricing; Adjusted EBIT margin 24.5% versus 22.9%.
- MedTech & Specialty Audio Q3 revenue was $67.0 million (+3.6%) on hearing health volumes; Adjusted EBIT margin 38.5% versus 40.5%, on higher incentive compensation.
- Group Q3 Adjusted EBIT was $42.4 million (23.0% margin); non-GAAP diluted EPS $0.38 versus $0.33. The non-GAAP gross margin dipped to 45.3% on inventory adjustments, factory costs, mix and ceramic capacitor production transfer costs.
- Knowles is adding PD headcount "to support future growth" and spending on PD capacity, including specialty film; 2026 capex is expected at approximately 5% of revenue.
- Nine-month adjusted free cash flow was $62.4 million (versus $81.2 million) on higher working capital and capex; $47.5 million of buybacks, with $81.5 million of authorization left.
- Knowles (KN) Q3 2026 Earnings Call Transcript
- Q3 2026 revenue was $184 million (+20%) and EPS $0.38; Precision Devices revenue was $117 million (+33%) with book-to-bill of 1.5 and orders of nearly $180 million.
- Q4 guidance: revenue of $180 million to $190 million and EPS of $0.39 to $0.43; full-year 2026 revenue growth of 16% at the midpoint and adjusted EBITDA growth of 24%.
- PD is close to capacity constraints; new capacity across most PD lines comes online from late Q1, fully available in the second half of 2027. Capex rises to 5% to 7% of revenue in 2027.
- Niew expects 2027 organic growth to keep beating the May 2025 Investor Day targets, with SAM expansion via attenuators, inductors, Micro Solutions (north of $5 million in 2027) and pulse power capacitors.
- Defense could accelerate in the next 12 to 18 months on rising budgets and munitions replacement; medical plus defense is roughly 60% of the business.
- The $75 million energy order is fully ramped with 6 to 7 quarters of delivery left; the former Cornell business went from 27%-28% to mid-30s gross margin, "with a clear path above 40%".
- Margin path: 100 basis points of gross margin a year plus operating leverage, from just over 25% EBITDA margin to 30% within 2 to 3 years; Knowles is seeking "another Cornell" acquisition.
- Knowles Q2 2026 Earnings Call Transcript
- Q2 2026 revenue was $167 million (+14%) and EPS 33 cents (+38%), both above the high end of guidance; PD revenue was $98 million (+25%) and MSA $69 million (+2%).
- PD book-to-bill was 1.4 (seventh straight quarter above one), with orders of nearly $140 million, broad-based across MedTech, defense, industrial and electrification.
- Full-year 2026 guidance was raised to revenue growth of 10% to 12% and adjusted EBITDA growth of 20% to 24%, well above Investor Day targets.
- Defense is growing faster than expected: filters are roughly $80 million (about ninety percent defense), Knowles is sole source on key programs, and a "$15 million plus" multi-year radar order was received.
- Pricing is "definitely stronger than it was last year"; Knowles raises PD prices annually and "We don't really see our prices go down."
- M&A is "very selective" (Cornell was "a real home run"); an Investor Day on growth platforms (energy, Micro Solutions, inductors, downhole) is likely in the first half of next year.
- CFO John Anderson sees EBITDA margins above 25% in 2026 and a path to "close to 30%" over two to three years.
Questions about Knowles Corporation
What does Knowles do?
Knowles makes specialty electronic components: high-performance capacitors and RF filters for defense, medtech, industrial and energy markets, and microphones and balanced armature speakers for hearing aids.
What is Knowles' revenue?
FY2025 revenue was $593.2 million, up 7.2%. For the first nine months of 2026 revenue was $503.9 million, up 16.9%.
How many employees does Knowles have?
Approximately 5,200 employees at facilities in 11 countries at December 31, 2025.
Who leads Knowles?
Jeffrey S. Niew has been President & CEO since September 2013; John S. Anderson is CFO and Daniel J. Giesecke COO.
What is Knowles' strategy?
Knowles is reshaping itself into an industrial technology company focused on Precision Devices and MedTech, adding PD capacity, growing defense and medtech content, and seeking selective acquisitions.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)